Precision Optics Corporation, Inc. (POCI)
USD 4.24
(3.16%)
USD 4.24
(3.16%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 1.93 Million USD | -12.73% |
| 2023 | 2.43 Million USD | -0.24% |
| 2022 | 2.43 Million USD | 1501.08% |
| 2021 | 152.39 Thousand USD | 57.02% |
| 2020 | 97.05 Thousand USD | 1830.71% |
| 2019 | 5027.00 USD | -65.57% |
| 2018 | 14.6 Thousand USD | -38.04% |
| 2017 | 23.56 Thousand USD | -26.26% |
| 2016 | 31.95 Thousand USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | -100.0% |
| 2008 | 10.3 Thousand USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | -100.0% |
| 2003 | 1555.00 USD | -91.22% |
| 2002 | 17.7 Thousand USD | -74.23% |
| 2001 | 68.7 Thousand USD | -22.08% |
| 2000 | 88.17 Thousand USD | -55.91% |
| 1999 | 200 Thousand USD | 0.0% |
| 1998 | 200 Thousand USD | 0.0% |
| 1997 | 200 Thousand USD | -33.33% |
| 1996 | 300 Thousand USD | 200.0% |
| 1995 | 100 Thousand USD | 0.0% |
| 1994 | 100 Thousand USD | 0.0% |
| 1993 | - USD | 0.0% |
| 1992 | - USD | -100.0% |
| 1991 | 200 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 2.25 Million USD | -5.9% |
| 2024 Q3 | 1.79 Million USD | -6.69% |
| 2024 Q2 | 2.06 Million USD | -6.27% |
| 2024 Q4 | 1.93 Million USD | 6.03% |
| 2023 Q2 | 2.13 Million USD | -6.36% |
| 2023 Q1 | 2.28 Million USD | -6.38% |
| 2023 FY | 2.43 Million USD | -0.24% |
| 2023 Q3 | 1.99 Million USD | -6.78% |
| 2023 Q4 | 2.43 Million USD | 22.08% |
| 2022 Q3 | 2.27 Million USD | -0.31% |
| 2022 FY | 2.43 Million USD | 1501.08% |
| 2022 Q1 | 142.44 Thousand USD | -6.53% |
| 2022 Q2 | 2.27 Million USD | 1498.75% |
| 2022 Q4 | 2.43 Million USD | 7.47% |
| 2021 Q3 | 177.87 Thousand USD | 185.19% |
| 2021 Q4 | 152.39 Thousand USD | -14.32% |
| 2021 FY | 152.39 Thousand USD | 57.02% |
| 2021 Q1 | 79.82 Thousand USD | -17.75% |
| 2021 Q2 | 62.37 Thousand USD | -21.87% |
| 2020 FY | 97.05 Thousand USD | 1830.71% |
| 2020 Q1 | 106.91 Thousand USD | 2026.82% |
| 2020 Q2 | 90.18 Thousand USD | -15.65% |
| 2020 Q3 | 113.8 Thousand USD | 26.2% |
| 2020 Q4 | 97.05 Thousand USD | -14.72% |
| 2019 FY | 5027.00 USD | -65.57% |
| 2019 Q4 | 5027.00 USD | -32.8% |
| 2019 Q1 | 12.26 Thousand USD | -15.99% |
| 2019 Q2 | 9894.00 USD | -19.34% |
| 2019 Q3 | 7481.00 USD | -24.39% |
| 2018 Q4 | 14.6 Thousand USD | -13.59% |
| 2018 FY | 14.6 Thousand USD | -38.04% |
| 2018 Q1 | 21.37 Thousand USD | -9.28% |
| 2018 Q2 | 19.15 Thousand USD | -10.39% |
| 2018 Q3 | 16.89 Thousand USD | -11.79% |
| 2017 Q3 | 25.71 Thousand USD | -7.6% |
| 2017 Q2 | 27.82 Thousand USD | -6.96% |
| 2017 FY | 23.56 Thousand USD | -26.26% |
| 2017 Q1 | 29.9 Thousand USD | -6.4% |
| 2017 Q4 | 23.56 Thousand USD | -8.36% |
| 2016 Q3 | 33.96 Thousand USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | 31.95 Thousand USD | -5.93% |
| 2016 FY | 31.95 Thousand USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q4 | - USD | -100.0% |
| 2009 FY | - USD | -100.0% |
| 2009 Q2 | 334.35 Thousand USD | 70.78% |
| 2009 Q3 | 399.22 Thousand USD | 19.4% |
| 2009 Q1 | 195.77 Thousand USD | 1800.03% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | 10.3 Thousand USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | 10.3 Thousand USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | -100.0% |
| 2004 FY | - USD | -100.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2003 FY | 1555.00 USD | -91.22% |
| 2003 Q4 | 1555.00 USD | -50.0% |
| 2003 Q3 | 3110.00 USD | -33.33% |
| 2003 Q2 | 4665.00 USD | -48.33% |
| 2003 Q1 | 9028.00 USD | -49.01% |
| 2002 FY | 17.7 Thousand USD | -74.23% |
| 2002 Q4 | 17.7 Thousand USD | -34.69% |
| 2002 Q3 | 27.1 Thousand USD | -23.74% |
| 2002 Q2 | 35.54 Thousand USD | -4.59% |
| 2002 Q1 | 37.25 Thousand USD | -45.77% |
| 2001 Q2 | 115.49 Thousand USD | 52.56% |
| 2001 Q4 | 68.7 Thousand USD | -21.24% |
| 2001 FY | 68.7 Thousand USD | -22.08% |
| 2001 Q1 | 75.7 Thousand USD | -14.14% |
| 2001 Q3 | 87.22 Thousand USD | -24.48% |
| 2000 Q2 | 100 Thousand USD | 0.0% |
| 2000 FY | 88.17 Thousand USD | -55.91% |
| 2000 Q3 | 100.24 Thousand USD | 0.25% |
| 2000 Q1 | 100 Thousand USD | -50.0% |
| 2000 Q4 | 88.17 Thousand USD | -12.04% |
| 1999 Q4 | 200 Thousand USD | 0.0% |
| 1999 FY | 200 Thousand USD | 0.0% |
| 1999 Q1 | 200 Thousand USD | 0.0% |
| 1999 Q2 | 200 Thousand USD | 0.0% |
| 1999 Q3 | 200 Thousand USD | 0.0% |
| 1998 Q1 | 200 Thousand USD | 0.0% |
| 1998 Q4 | 200 Thousand USD | 0.0% |
| 1998 Q3 | 200 Thousand USD | -33.33% |
| 1998 Q2 | 300 Thousand USD | 50.0% |
| 1998 FY | 200 Thousand USD | 0.0% |
| 1997 Q2 | 200 Thousand USD | -33.33% |
| 1997 Q4 | 200 Thousand USD | 0.0% |
| 1997 FY | 200 Thousand USD | -33.33% |
| 1997 Q1 | 300 Thousand USD | 0.0% |
| 1997 Q3 | 200 Thousand USD | 0.0% |
| 1996 FY | 300 Thousand USD | 200.0% |
| 1996 Q3 | 300 Thousand USD | 200.0% |
| 1996 Q1 | 100 Thousand USD | 0.0% |
| 1996 Q2 | 100 Thousand USD | 0.0% |
| 1996 Q4 | 300 Thousand USD | 0.0% |
| 1995 Q3 | 100 Thousand USD | 0.0% |
| 1995 Q4 | 100 Thousand USD | 0.0% |
| 1995 Q2 | 100 Thousand USD | -50.0% |
| 1995 Q1 | 200 Thousand USD | 100.0% |
| 1995 FY | 100 Thousand USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | 100 Thousand USD | 0.0% |
| 1994 Q4 | 100 Thousand USD | 0.0% |
| 1994 FY | 100 Thousand USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q1 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1992 FY | - USD | -100.0% |
| 1992 Q4 | - USD | 0.0% |
| 1991 FY | 200 Thousand USD | 0.0% |
| 1991 Q4 | 200 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 75.25 Million USD | 97.425% |
| AngioDynamics, Inc. | 3.93 Million USD | 50.8% |
| AtriCure, Inc. | 60.59 Million USD | 96.802% |
| Avinger, Inc. | - USD | -Infinity% |
| Azenta, Inc. | 60.43 Million USD | 96.793% |
| BioLife Solutions, Inc. | 18.31 Million USD | 89.416% |
| The Cooper Companies, Inc. | 2.52 Billion USD | 99.923% |
| Daxor Corporation | 755.65 Thousand USD | -156.461% |
| Ekso Bionics Holdings, Inc. | 4.83 Million USD | 59.893% |
| Femasys Inc. | 4.25 Million USD | 54.488% |
| GlucoTrack, Inc. | 196 Thousand USD | -888.76% |
| Harvard Bioscience, Inc. | 30.7 Million USD | 93.688% |
| Hologic, Inc. | 2.49 Billion USD | 99.922% |
| ICU Medical, Inc. | 1.57 Billion USD | 99.877% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 102.36% |
| KORU Medical Systems, Inc. | 3.65 Million USD | 46.947% |
| LeMaitre Vascular, Inc. | 16.62 Million USD | 88.342% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 871.7 Million USD | 99.778% |
| Microbot Medical Inc. | 40 Thousand USD | -4744.925% |
| Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -42103.179% |
| Merit Medical Systems, Inc. | 823.01 Million USD | 99.765% |
| Nephros, Inc. | 1.39 Million USD | -39.422% |
| NovoCure Limited | 596.24 Million USD | 99.675% |
| NEXGEL, Inc. | 513 Thousand USD | -277.772% |
| NEXGEL, Inc. | 513 Thousand USD | -277.772% |
| Singular Genomics Systems, Inc. | 67.52 Million USD | 97.13% |
| OraSure Technologies, Inc. | 11.38 Million USD | 82.982% |
| Pro-Dex, Inc. | 7.53 Million USD | 74.284% |
| Pulse Biosciences, Inc. | 8.08 Million USD | 76.033% |
| Predictive Oncology Inc. | 2.18 Million USD | 11.467% |
| QuidelOrtho Corporation | 2.27 Billion USD | 99.915% |
| Repligen Corporation | 510.14 Million USD | 99.62% |
| Sanara MedTech Inc. | 9.11 Million USD | 78.734% |
| STAAR Surgical Company | 31.46 Million USD | 93.841% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 295 Thousand USD | -556.939% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.892% |
| Jin Medical International Ltd. | - USD | -Infinity% |